MarketCap
Facebook
X
TelegramQuarterly report 2025-Q1
added 05-01-2025
Blueprint Medicines Corporation Total Inventories 2011-2026 | BPMC
Annual Total Inventories Blueprint Medicines Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.6 M | 21.2 M | 29.7 M | 21.8 M | 8.58 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 29.7 M | 8.58 M | 19 M |
Quarterly Total Inventories Blueprint Medicines Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13 M | 13.6 M | 12.5 M | 14.8 M | 30.9 M | 21.2 M | 16.5 M | 17 M | 17.5 M | 29.7 M | 35.3 M | - | 30.1 M | 21.8 M | 16.6 M | 15.2 M | 16 M | 8.58 M | 8.58 M | 8.58 M | 8.58 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 35.3 M | 8.58 M | 17.8 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Amphastar Pharmaceuticals
AMPH
|
177 M | $ 21.75 | 1.59 % | $ 1.02 B |  USA |
 |
Aptorum Group Limited
APM
|
39.1 K | $ 0.91 | 1.61 % | $ 6.69 M |  China |
 |
ACADIA Pharmaceuticals
ACAD
|
91.7 M | $ 22.29 | 1.5 % | $ 3.69 B | USA |
 |
Aquestive Therapeutics
AQST
|
6.17 M | $ 4.1 | 0.37 % | $ 438 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 23.2 | -0.26 % | $ 2.95 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.42 | -1.39 % | $ 378 M |  Britain |
 |
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | USA |
 |
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
bluebird bio
BLUE
|
22.9 M | - | - | $ 546 M | USA |
 |
BioXcel Therapeutics
BTAI
|
722 K | $ 1.07 | 0.94 % | $ 13.1 M | USA |
 |
Cara Therapeutics
CARA
|
2.82 M | - | -3.03 % | $ 260 M | USA |
 |
Esperion Therapeutics
ESPR
|
105 M | $ 1.95 | 1.83 % | $ 405 M | USA |
 |
CASI Pharmaceuticals
CASI
|
1.91 M | - | - | $ 35.4 M | USA |